These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15701205)

  • 1. Focus on levomepromazine.
    Green B; Pettit T; Faith L; Seaton K
    Curr Med Res Opin; 2004 Dec; 20(12):1877-81. PubMed ID: 15701205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levomepromazine (methotrimeprazine) and the last 48 hours.
    O'Neill J; Fountain A
    Hosp Med; 1999 Aug; 60(8):564-7. PubMed ID: 10621810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Little effects of low dosage of levomepromazine on plasma risperidone levels.
    Yoshimura R; Shinkai K; Kakihara S; Goto M; Yamada Y; Kaji K; Ueda N; Nakamura J
    Pharmacopsychiatry; 2005 Mar; 38(2):98-100. PubMed ID: 15744635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photooxidation mechanism of levomepromazine in different solvents.
    Piñero-Santiago LE; García C; Lhiaubet-Vallet V; Trzcionka J; Oyola R; Torres K; Leguillú J; Miranda MA
    Photochem Photobiol; 2013; 89(6):1479-89. PubMed ID: 23909411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive-behavioral therapy for medication-resistant schizophrenia: a review.
    Rathod S; Kingdon D; Weiden P; Turkington D
    J Psychiatr Pract; 2008 Jan; 14(1):22-33. PubMed ID: 18212600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience and management considerations with long-acting risperidone.
    Parellada E
    Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levomepromazine for schizophrenia.
    Sivaraman P; Rattehalli R; Jayaram M
    Schizophr Bull; 2012 Mar; 38(2):219-20. PubMed ID: 22114097
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment.
    Altamura AC; Bobo WV; Meltzer HY
    Int Clin Psychopharmacol; 2007 Sep; 22(5):249-67. PubMed ID: 17690594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting risperidone: focus on safety.
    Möller HJ
    Clin Ther; 2006 May; 28(5):633-51. PubMed ID: 16861087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levomepromazine for nausea and vomiting in palliative care.
    Darvill E; Dorman S; Perkins P
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009420. PubMed ID: 23633372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrimeprazine for the management of end-of-life symptoms in infants and children.
    Hohl CM; Stenekes S; Harlos MS; Shepherd E; McClement S; Chochinov HM
    J Palliat Care; 2013; 29(3):178-85. PubMed ID: 24380217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and safety of antipsychotic drugs during pregnancy.
    Einarson A; Boskovic R
    J Psychiatr Pract; 2009 May; 15(3):183-92. PubMed ID: 19461391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic drugs in the human brain: clinical impact of persistence and region-specific distribution.
    Kornhuber J; Wiltfang J; Riederer P; Bleich S
    Eur Arch Psychiatry Clin Neurosci; 2006 Aug; 256(5):274-80. PubMed ID: 16788768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia.
    Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y
    Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations.
    Scolnick EM
    Biol Psychiatry; 2006 Jun; 59(11):1039-45. PubMed ID: 16616720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk for obstruction of the airways in the parenteral use of levomepromazine with benzodiazepine.
    Hatta K; Takahashi T; Nakamura H; Yamashiro H; Endo H; Kito K; Saeki T; Masui K; Yonezawa Y
    Pharmacopsychiatry; 1998 Jul; 31(4):126-30. PubMed ID: 9754846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
    Fowler JA; Bettinger TL; Argo TR
    Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.